Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.39 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
| ▸ | CASP7 | P55210 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28962436 | 0.76 | MAPK1 (0.55) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL131080 | 0.76 | MAPK1 (0.55) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL133155 | 0.73 | MEN1 (0.52) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL4073489 | 0.73 | MAPK1 (0.74) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL7557528 | 0.73 | MAPK1 (0.52) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL130420 | 0.73 | KMT2A (0.59) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL131079 | 0.73 | MAPK1 (0.52) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL58539 | 0.73 | MAPK1 (0.57) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL3289050 | 0.73 | MAPK1 (0.52) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL4507358 | 0.73 | MAPK1 (0.52) | MAPK1MEN1KMT2AMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0642530-B1 | DERIVATIVES OF DOLASTATIN | BASF AG (DE) | 1998-08-12 | — | — | EP | claimed |
| US-5502032-A | SYNTHETIC OLIGOPEPTIDES, ANTITUMOR, ANTICANCER | BASF AKTIENGESELLSCHAFT (DE) | 1996-03-26 | — | — | US | claimed |
| EP-0674652-A1 | DOLOSTATIN ANALOG | BASF AKTIENGESELLSCHAFT (DE) | 1995-10-04 | — | — | EP | claimed |
| EP-0642530-A1 | DERIVATIVES OF DOLASTATIN | BASF Aktiengesellschaft (DE) | 1995-03-15 | — | — | EP | claimed |
| WO-1994013695-A1 | DOLOSTATIN ANALOG | BASF AKTIENGESELLSCHAFT (DE) | 1994-06-23 | — | — | WO | claimed |
| WO-1993023424-A1 | DERIVATIVES OF DOLASTATIN | BASF AKTIENGESELLSCHAFT (DE) | 1993-11-25 | — | — | WO | claimed |
| US-20240065267-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-11805779-B2 | Plant disease control composition and method for controlling plant disease by applying the same | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2023-11-07 | — | — | US | disclosed |
| US-20210000112-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | MITSUI CHEMICALS AGRO, INC. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-10806141-B2 | Plant disease control composition and method for controlling plant disease by applying the same | MITSUI CHEMICALS AGRO, INC. (JP) | 2020-10-20 | — | — | US | disclosed |
| EP-3263109-B1 | DRUG FOR PREVENTING AND/OR TREATING DEMENTIA | NAT UNIV CORP TOTTORI UNIV (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-10428019-B2 | Chiral auxiliaries | WAVE LIFE SCIENCES LTD. (SG) | 2019-10-01 | — | — | US | disclosed |
| US-10413546-B2 | Drug for preventing and/or treating dementia | NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY (JP) | 2019-09-17 | — | — | US | disclosed |
| EP-0642530-B1 | DERIVATIVES OF DOLASTATIN | BASF AG (DE) | 1998-08-12 | — | — | EP | disclosed |
| US-5502032-A | SYNTHETIC OLIGOPEPTIDES, ANTITUMOR, ANTICANCER | BASF AKTIENGESELLSCHAFT (DE) | 1996-03-26 | — | — | US | disclosed |
| EP-0674652-A1 | DOLOSTATIN ANALOG | BASF AKTIENGESELLSCHAFT (DE) | 1995-10-04 | — | — | EP | disclosed |
| EP-0642530-A1 | DERIVATIVES OF DOLASTATIN | BASF Aktiengesellschaft (DE) | 1995-03-15 | — | — | EP | disclosed |
| WO-1994013695-A1 | DOLOSTATIN ANALOG | BASF AKTIENGESELLSCHAFT (DE) | 1994-06-23 | — | — | WO | disclosed |
| WO-1993023424-A1 | DERIVATIVES OF DOLASTATIN | BASF AKTIENGESELLSCHAFT (DE) | 1993-11-25 | — | — | WO | disclosed |
| EP-0562832-A1 | Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use | SANKYO COMPANY LIMITED (JP) | 1993-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240065267-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | SNX1, HAX1, BROX | MAPK1 3492/4885MEN1 1867/4885KMT2A 1298/4885 |
| US-10806141-B2 | Plant disease control composition and method for controlling plant disease by applying the same | SNX1, HAX1, BROX | MAPK1 3521/4885MEN1 1880/4885KMT2A 1329/4885 |
| US-10428019-B2 | Chiral auxiliaries | PCNA, POLL, TYMP | MAPK1 3683/4885MEN1 1480/4885KMT2A 3540/4885 |
| US-10413546-B2 | Drug for preventing and/or treating dementia | XDH, ACHE, DDO | MAPK1 1503/4885MEN1 3422/4885KMT2A 2718/4885 |
| US-11805779-B2 | Plant disease control composition and method for controlling plant disease by applying the same | SNX1, HAX1, BROX | MAPK1 3492/4885MEN1 1867/4885KMT2A 1298/4885 |
| US-20210000112-A1 | PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLYING THE SAME | SNX1, HAX1, BROX | MAPK1 3492/4885MEN1 1867/4885KMT2A 1298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.